PREVENTion of Clot in Orthopaedic Trauma
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 12424 participants.
Also called NCT02984384
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 12,424 participants
- Registry
-
NCT02984384
-
- Other papers using this trial's data
- Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT02984384. Randomized; single masking; primary purpose prevention. Start 2017-04-24 (actual); primary completion 2022-02-18 (actual). Results posted on 2024-05-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PREVENTion of Clot in Orthopaedic Trauma
- Acronym
- PREVENT CLOT
- Condition
- Blood Clot
- Condition
- Trauma
- Intervention (Drug)
- Acetylsalicylic acid
- Intervention (Drug)
- Low Molecular Weight Heparin (LMWH)
- Lead sponsor
- Major Extremity Trauma Research Consortium
- Collaborator
- Patient-Centered Outcomes Research Institute
Record details
- Record id
cardio:ct-nct02984384- Content hash
0a7f5e53e4a3b6c12f5a69a36c7b76825f8f58930440169f1f87ce81d882af07